Epstein-Barr Virus Infection Mimicking Drug-Induced Hepatitis in a Critically ill Patient During Antituberculosis Therapy

Authors Information
Article Notes and Dates
To Cite : Wang C, Li Y, Shen C. Epstein-Barr Virus Infection Mimicking Drug-Induced Hepatitis in a Critically ill Patient During Antituberculosis Therapy, Hepat Mon. 2014 ;14(9):e18865. doi: 10.5812/hepatmon.18865.
Copyright: Copyright © 2014, Hepatitis Monthly. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited..
1. Introduction
2. Case Presentation
3. Discussion
  • 1. Horwitz CA, Burke MD, Grimes P, Tombers J. Hepatic function in mononucleosis induced by Epstein-Barr virus and cytomegalovirus. Clin Chem. 1980; 26(2): 243-6[PubMed]
  • 2. Kofteridis DP, Koulentaki M, Valachis A, Christofaki M, Mazokopakis E, Papazoglou G, et al. Epstein Barr virus hepatitis. Eur J Intern Med. 2011; 22(1): 73-6[DOI][PubMed]
  • 3. Hawker F. Liver dysfunction in critical illness. Anaesth Intensive Care. 1991; 19(2): 165-81[PubMed]
  • 4. Tostmann A, Boeree MJ, Aarnoutse RE, de Lange WC, van der Ven AJ, Dekhuijzen R. Antituberculosis drug-induced hepatotoxicity: concise up-to-date review. J Gastroenterol Hepatol. 2008; 23(2): 192-202[DOI][PubMed]
  • 5. Saukkonen JJ, Cohn DL, Jasmer RM, Schenker S, Jereb JA, Nolan CM, et al. An official ATS statement: hepatotoxicity of antituberculosis therapy. Am J Respir Crit Care Med. 2006; 174(8): 935-52[DOI][PubMed]
  • 6. Sharma SK, Singla R, Sreenivas V, Kumar S, Jha B, Rathored J, et al. Acute viral hepatitis as a confounding factor in patients with antituberculosis treatment induced hepatotoxicity. Indian J Med Res. 2009; 130(2): 200-1[PubMed]
  • 7. Sarda P, Sharma SK, Mohan A, Makharia G, Jayaswal A, Pandey RM, et al. Role of acute viral hepatitis as a confounding factor in antituberculosis treatment induced hepatotoxicity. Indian J Med Res. 2009; 129(1): 64-7[PubMed]
  • 8. Losavio AD, Te HS. Epstein-barr virus: an unusual cause of cholestatic hepatitis in older adults. Gastroenterol Hepatol (N Y). 2007; 3(2): 101-5[PubMed]
  • 9. Vine LJ, Shepherd K, Hunter JG, Madden R, Thornton C, Ellis V, et al. Characteristics of Epstein-Barr virus hepatitis among patients with jaundice or acute hepatitis. Aliment Pharmacol Ther. 2012; 36(1): 16-21[DOI][PubMed]
  • 10. Kimura H, Nagasaka T, Hoshino Y, Hayashi N, Tanaka N, Xu JL, et al. Severe hepatitis caused by Epstein-Barr virus without infection of hepatocytes. Hum Pathol. 2001; 32(7): 757-62[PubMed]
  • 11. Markin RS, Linder J, Zuerlein K, Mroczek E, Grierson HL, Brichacek B, et al. Hepatitis in fatal infectious mononucleosis. Gastroenterology. 1987; 93(6): 1210-7[PubMed]
  • 12. Cacopardo B, Nunnari G, Mughini MT, Tosto S, Benanti F, Nigro L. Fatal hepatitis during Epstein-Barr virus reactivation. Eur Rev Med Pharmacol Sci. 2003; 7(4): 107-9[PubMed]
  • 13. Papatheodoridis G. Fulminant hepatitis due to Epstein-Barr virus infection. J Hepatology. 1995; 23(3): 348-50[DOI]
  • 14. Diehl AM. Cytokine regulation of liver injury and repair. Immunol Rev. 2000; 174: 160-71[PubMed]
  • 15. Kerr JR, Mattey DL. Preexisting psychological stress predicts acute and chronic fatigue and arthritis following symptomatic parvovirus B19 infection. Clin Infect Dis. 2008; 46(9)-7[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiaion Alert via Google Reader

Cited By:

Hepatitis Monthly accepts terms & conditions of:

International Committee of Medical Journal Editors (ICMJE) Citedby Linking DOI enabled Crossref iThenticate COPE Cross Check